Cancer

Our cancer research focuses on using economic analysis to improve the delivery and outcomes of cancer care. It draws on the Centre’s key methodological strengths including the use of discrete choice experiments to understand the factors that influence patients and providers to participate in care, developing different approaches to the measurement and valuation of quality of life in cancer patients, understanding provider incentives in care, and the use of existing administrative data sets to explore utilization and costs of cancer care. In addition, the principles of economic evaluation underpin a major component of the work in cancer at CHERE: the Cancer Australia Cancer Research Economic Support Team (CREST). CREST provides high quality expert advice and support to the 14 Cancer Australia Multi-site Collaborative Cancer Clinical Trials Groups (CTGs) on the use of health economics approaches, particularly economic evaluation, to evaluate the costs and outcomes of interventions being tested in cancer clinical trials. While a core focus of CREST is on the provision of advice, the ultimate aim of the work is to build capacity within the cancer research community for the conduct of health economic research alongside clinical trials.

For more information: Assoc Prof Richard De Abreu Lourenco, Professor Marion Haas